Jessica R. Tait

Evaluation of Meropenem‐Ciprofloxacin Combination Dosage Regimens for the Pharmacokinetics of Critically Ill Patients With Augmented Renal Clearance

Akosua Adom Agyeman, Kate E. Rogers, Jessica R. Tait et al. · Clinical Pharmacology & Therapeutics · 2021 · 23 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +13

Clinically Relevant Epithelial Lining Fluid Concentrations of Meropenem with Ciprofloxacin Provide Synergistic Killing and Resistance Suppression of Hypermutable Pseudomonas aeruginosa in a Dynamic Biofilm Model

Hajira Bilal, Phillip J. Bergen, Jessica R. Tait et al. · Antimicrobial Agents and Chemotherapy · 2020 · 13 citations · Full text

Life Sciences, Microbiology, Pharmacotherapy +17

Pharmacodynamics of ceftazidime plus tobramycin combination dosage regimens against hypermutable Pseudomonas aeruginosa isolates at simulated epithelial lining fluid concentrations in a dynamic in vitro infection model

Jessica R. Tait, Hajira Bilal, Tae‐Hwan Kim et al. · Journal of Global Antimicrobial Resistance · 2021 · 13 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Ceftolozane-Tazobactam against Pseudomonas aeruginosa Cystic Fibrosis Clinical Isolates in the Hollow-Fiber Infection Model: Challenges Imposed by Hypermutability and Heteroresistance

Jessica R. Tait, Marina Harper, Sara Cortés-Lara et al. · Antimicrobial Agents and Chemotherapy · 2023 · 11 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14